Market brief — July 1, 2026

US and European markets extended their rebound into early Wednesday, with the S&P 500 gaining 0.79% to 7,499.36 and the Nasdaq surging 1.52% to 26,213.72, while European indices led the advance as the DAX rose 1.5% to 24,995.81 and the Euro Stoxx 50 climbed 1.55% to 6,328.09^[1][2]. The CAC 40 added 0.44% to 8,403.99, confirming a broad risk-on unwind of crowded semiconductor longs and a rotation toward cyclicals and biotech driven by easing Middle East tensions and a pause in US-Iran hostilities^[1][2]. This fresh risk-taking reflects investors recalibrating AI profit optimism after volatile chip moves, with macro flows shifting from AI momentum to sectors with tangible earnings supported by stable Treasury yields and a firm dollar^[2].

The macro narrative links directly to sector flows: biotech and building stocks are outperforming as short-covering accelerates, while banking and insurance show resilience amid repriced rate expectations. Cross-asset confirmation comes from stable credit spreads in the mid-70s and a firm dollar, implying discretionary positioning rather than CTA/vol-driven moves^[2]. A key divergence persists—equities rise while yields remain flat—suggesting the market is de-risking without inflation fears, a setup that favors cyclicals over defensives.

Today’s Cash Scanner TOP 10 reveals concentrated momentum in US biotech and European banking, with COGENT BIOSCIENCES INC (COGT) scoring 39, gap -0.1%, and a vortex↑ signal alongside KST↑^[1]. Fortune Brands Home & Security (FBIN) surged 7.7% with a 20j breakout and ADX 26, while AXA SA (CS.PA) posted a 1.1% gap, score 45, and a 20j breakout with ADX 37^[1]. The sector mix—2× biotech, 2× banking/insurance, 1× building—aligns with the broader rotation away from AI momentum toward earnings-backed sectors, signaling early regime shift toward cyclicals.

Key agenda items include US student loan repayment plan changes starting July 1, which may affect consumer spending and credit flows^[3]; Canada-US-Mexico trade talks on CUSMA, potentially impacting cross-border equities^[6]; and Nike’s Q2 earnings, which could sway consumer discretionary sentiment^[2]. These events are unlikely to shift rate expectations but may increase volatility in consumer and trade-sensitive sectors.

Risks to watch include a surprise in US industrial output data (currently 5.1% YoY growth), which could reignite inflation fears^[1]; a central bank shift in rate path signaling, especially if yields break stability; and geopolitical escalation if Middle East tensions flare, disrupting the current de-risking trend.

Actionable lines: COGENT BIOSCIENCES (COGT) above 39.50 with volume confirmation for biotech momentum; Fortune Brands (FBIN) above 55.50 if the 20j breakout holds; and the S&P 500 above 7,520 as a confirmation of sustained risk-on positioning.

Bonne journée aux p&l makers.